Literature DB >> 21263996

Increasing the benefits of chemotherapy by ameliorating the adverse effects.

L A Fernandez.   

Abstract

When cancer is first diagnosed in most patients, it is usually incurable. Chemotherapy can cause remissions, prolonged disease-free survival, and prolonged survival in general, but it is associated with considerable toxicity to the physical and mental well-being of the patient. The number of side-effects increases when multiple drug combinations are used. In addition, financial and social problems add to the stress of coping with a fatal disease. Therefore both patients and physicians have asked whether survival (sometimes for extra months) with added side-effects of chemotherapy is worthwhile. The "soft" index of quality of life has been measured by many investigators, and a variety of interventions have been found to alleviate some distress.

Entities:  

Year:  1987        PMID: 21263996      PMCID: PMC2218691     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  9 in total

1.  Dangers of uric-acid excretion during treatment of leukaemia and lymphosarcoma.

Authors:  D GREENBAUM; H F H STONE
Journal:  Lancet       Date:  1959-01-10       Impact factor: 79.321

2.  Quality of life measurements in patients with malignant disease: a review.

Authors:  A Clark; L J Fallowfield
Journal:  J R Soc Med       Date:  1986-03       Impact factor: 5.344

3.  Prevention of doxorubicin-induced hair loss with scalp hypothermia.

Authors:  J C Dean; S E Salmon; K S Griffith
Journal:  N Engl J Med       Date:  1979-12-27       Impact factor: 91.245

Review 4.  The clinical toxicity of anticancer drugs and its prediction.

Authors:  P J Creaven; E Mihich
Journal:  Semin Oncol       Date:  1977-06       Impact factor: 4.929

5.  Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs.

Authors:  R J Ignoffo; M A Friedman
Journal:  Cancer Treat Rev       Date:  1980-03       Impact factor: 12.111

6.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.

Authors:  H Schipper; J Clinch; A McMurray; M Levitt
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

7.  Quality of life and state of health for patients with cancer in the head and neck.

Authors:  B Drettner; A Ahlbom
Journal:  Acta Otolaryngol       Date:  1983 Sep-Oct       Impact factor: 1.494

8.  Effect of cytotoxic therapy on sexuality and gonadal function.

Authors:  R M Chapman
Journal:  Semin Oncol       Date:  1982-03       Impact factor: 4.929

Review 9.  Hypersensitivity reactions to cancer chemotherapeutic agents.

Authors:  R B Weiss; S Bruno
Journal:  Ann Intern Med       Date:  1981-01       Impact factor: 25.391

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.